"Short Sellers Retreat Amid Rally," ran the headline in the Wall Street Journal. Curious readers stopped and stared. It was the premise of the headline that arrested them. Who knew that there was even one bear left to give ground at the 100-month mark of the post-2008 levitation? El toro is the topic at hand. It's a most unusual bull market (we count as one the updrafts in stocks and bonds). An unzestful, low-volume, and low-volatility affair, it seems to belong on a psychiatrist's couch. We write to catalogue its singularities with the purpose of addressing the always pertinent question: What to do with money besides enjoy it? No. 1 is the zest deficit. Since the S&P 500 Index bottomed at an intraday low of 666.79 on March 6, 2009, the blue chips have appreciated by 271%. The country has grown, too, although – famously – the economic expansion leaves much to be desired. Trailing 12-month earnings for the S&P 500 peaked in the third quarter of 2014, and disappointments abound in the data that purport to measure growth in GDP and productivity.
Top Blue Chip Stocks To Invest In Right Now: Ohr Pharmaceuticals, Inc.(OHRP)
- [By Joseph Griffin]
OHR Pharmaceutical Inc (NASDAQ:OHRP)’s share price fell 9.1% during trading on Tuesday . The stock traded as low as $0.22 and last traded at $0.24. 16,800 shares were traded during trading, a decline of 98% from the average session volume of 1,040,668 shares. The stock had previously closed at $0.22.
- [By Paul Ausick]
Ohr Pharmaceuticals Inc. (NASDAQ: OHRP) dropped nearly 13% Tuesday to post a new 52-week low of $0.24. Shares closed at $0.27 on Friday and the stock’s 52-week high is $2.18. Volume was around 1 million, about a third of the daily average of about 3.3 million. The company had no specific news Tuesday.
- [By Paul Ausick]
Ohr Pharmaceuticals Inc. (NASDAQ: OHRP) dropped nearly 83% Friday to post a new 52-week low of $0.35 after closing at $2.02 on Thursday. The stock’s 52-week hig is $2.18. Volume was around 32.6 million, more than 30 times the daily average of around 1.2 million. The company reported that topline data from a clinical study failed to meet its primary endpoint.
Top Blue Chip Stocks To Invest In Right Now: Third Point Reinsurance Ltd.(TPRE)
- [By Ethan Ryder]
Third Point Reinsurance (NYSE:TPRE) was upgraded by analysts at ValuEngine from a sell rating to a hold rating.
Ternium (NYSE:TX) was upgraded by analysts at ValuEngine from a strong sell rating to a sell rating.
Top Blue Chip Stocks To Invest In Right Now: Adient plc (ADNT)
- [By Motley Fool Transcription]
Adient PLC (NYSE:ADNT)Q1 2019 Earnings Conference CallFeb. 7, 2019, 8:30 a.m. ET
Prepared Remarks Questions and Answers Call Participants
- [By Dan Caplinger]
Monday was another positive day for the stock market, with major benchmarks seeing small advances to start the week. Most investors focused on Singapore, where U.S. President Donald Trump is expected to meet with North Korean leader Kim Jong Un. Geopolitical issues have weighed on market sentiment for some time, so any sort of favorable resolution to tensions on the nuclear front could be embraced by Wall Street. Still, some companies had bad news today that held back their shares. Adient (NYSE:ADNT), CRISPR Therapeutics (NASDAQ:CRSP), and Applied Optoelectronics (NASDAQ:AAOI) were among the worst performers on the day. Here’s why they did so poorly.
- [By Shane Hupp]
Bank of New York Mellon Corp cut its position in shares of Adient PLC (NYSE:ADNT) by 7.1% in the second quarter, HoldingsChannel reports. The institutional investor owned 341,777 shares of the company’s stock after selling 25,967 shares during the period. Bank of New York Mellon Corp’s holdings in Adient were worth $16,812,000 at the end of the most recent quarter.
Top Blue Chip Stocks To Invest In Right Now: Vanguard Mega Cap Growth ETF (MGK)
- [By Ethan Ryder]
Fernwood Investment Management LLC lessened its stake in VANGUARD MEGA CAP 300 GROWTH ETF (BMV:MGK) by 9.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 17,022 shares of the company’s stock after selling 1,698 shares during the period. VANGUARD MEGA CAP 300 GROWTH ETF comprises 1.1% of Fernwood Investment Management LLC’s portfolio, making the stock its 26th biggest holding. Fernwood Investment Management LLC owned approximately 0.06% of VANGUARD MEGA CAP 300 GROWTH ETF worth $1,911,000 as of its most recent filing with the SEC.
Top Blue Chip Stocks To Invest In Right Now: Penn Virginia Resource Partners LP(PVR)
- [By Stephan Byrd]
PVR Partners, L.P. (PVR) is engaged in the gathering and processing of natural gas and the management of coal and natural resource properties in the United States. The Company operates in three business segments: Eastern Midstream, Midcontinent Midstream and Coal and Natural Resource Management. In March 2014, Regency Energy Partners LP announced that it has acquired acquires all of PVR Partners, L.P’s outstanding units.